"CD36 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
Descriptor ID |
D018955
|
MeSH Number(s) |
D12.776.157.530.300.500 D12.776.395.550.625.136 D12.776.543.550.625.136 D12.776.543.585.300.500 D12.776.543.750.011 D12.776.543.750.705.675.136 D12.776.543.750.705.940.625.249 D12.776.543.750.710.450.750.625.249
|
Concept/Terms |
CD36 Antigens- CD36 Antigens
- Antigens, CD36
- Thrombospondin Receptor
- Receptor, Thrombospondin
- Receptors, Thrombospondin
- Thrombospondin Receptors
- OKM5 Antigen
- Antigen, OKM5
- Platelet Glycoprotein IV
- Glycoprotein IV, Platelet
- Platelet Membrane Glycoprotein IIIb
- Platelet Glycoprotein IIIb
- Glycoprotein IIIb, Platelet
- SR-BI Protein
- SR BI Protein
- Adipocyte Membrane Protein p88
- CD36 Fatty Acid Transporter
- FAT (Fatty Acid Translocase) - CD36 Antigen
- CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)
- GPIV Platelet Glycoprotein
- Platelet Glycoprotein, GPIV
- GPIIIb Platelet Glycoprotein
- Platelet Glycoprotein, GPIIIb
- Scavenger Receptors, Class B, Type I
- SR-BI Receptor
- Receptor, SR-BI
- SR BI Receptor
- CD36 Protein
- CD36 Antigen
- Antigen, CD36
- Platelet Membrane Glycoprotein IV
|
Below are MeSH descriptors whose meaning is more general than "CD36 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Fatty Acid Transport Proteins [D12.776.157.530.300]
- CD36 Antigens [D12.776.157.530.300.500]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Platelet Membrane Glycoproteins [D12.776.395.550.625]
- CD36 Antigens [D12.776.395.550.625.136]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Platelet Membrane Glycoproteins [D12.776.543.550.625]
- CD36 Antigens [D12.776.543.550.625.136]
- Membrane Transport Proteins [D12.776.543.585]
- Fatty Acid Transport Proteins [D12.776.543.585.300]
- CD36 Antigens [D12.776.543.585.300.500]
- Receptors, Cell Surface [D12.776.543.750]
- CD36 Antigens [D12.776.543.750.011]
- Receptors, Immunologic [D12.776.543.750.705]
- Platelet Membrane Glycoproteins [D12.776.543.750.705.675]
- CD36 Antigens [D12.776.543.750.705.675.136]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class B [D12.776.543.750.705.940.625]
- CD36 Antigens [D12.776.543.750.705.940.625.249]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class B [D12.776.543.750.710.450.750.625]
- CD36 Antigens [D12.776.543.750.710.450.750.625.249]
Below are MeSH descriptors whose meaning is more specific than "CD36 Antigens".
This graph shows the total number of publications written about "CD36 Antigens" by people in this website by year, and whether "CD36 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 2 | 3 |
2018 | 3 | 3 | 6 |
2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "CD36 Antigens" by people in Profiles.
-
Elongated PEO-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger receptor class B I (SR-BI). J Control Release. 2021 09 10; 337:448-457.
-
IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol. 2021 03 05; 4(1):290.
-
Conus venom fractions inhibit the adhesion of Plasmodium falciparum erythrocyte membrane protein 1 domains to the host vascular receptors. J Proteomics. 2021 03 15; 234:104083.
-
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats. Biochem Pharmacol. 2019 12; 170:113677.
-
Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways. EBioMedicine. 2019 Mar; 41:50-61.
-
Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function. FASEB J. 2019 02; 33(2):2278-2289.
-
Evaluation of novel Parkinson's disease candidate genes in the Chinese population. Neurobiol Aging. 2019 02; 74:235.e1-235.e4.
-
CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis. FASEB J. 2019 02; 33(2):1860-1872.
-
PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages. Cardiovasc Res. 2018 07 01; 114(8):1145-1153.
-
Cardioprotective effect of ß-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model. Immunopharmacol Immunotoxicol. 2018 Aug; 40(4):284-289.